KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.58 $2.30 Friday, 26th Apr 2024 CTMX stock ended at $1.59. This is 0.625% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.77% from a day low at $1.59 to a day high of $1.65.
90 days $1.38 $2.86
52 weeks $1.04 $2.86

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Jul 12, 2023 $1.85 $1.86 $1.81 $1.84 134 356
Jul 11, 2023 $1.86 $1.87 $1.83 $1.83 113 033
Jul 10, 2023 $1.81 $1.88 $1.78 $1.86 280 554
Jul 07, 2023 $1.78 $1.82 $1.77 $1.79 213 296
Jul 06, 2023 $1.79 $1.84 $1.71 $1.81 478 645
Jul 05, 2023 $1.76 $1.83 $1.75 $1.80 581 470
Jul 03, 2023 $1.73 $1.79 $1.65 $1.78 517 201
Jun 30, 2023 $1.64 $1.78 $1.60 $1.72 3 861 033
Jun 29, 2023 $1.41 $1.45 $1.40 $1.41 282 573
Jun 28, 2023 $1.45 $1.44 $1.40 $1.41 184 861
Jun 27, 2023 $1.47 $1.47 $1.41 $1.41 310 941
Jun 26, 2023 $1.52 $1.52 $1.45 $1.46 380 666
Jun 23, 2023 $1.52 $1.55 $1.49 $1.54 221 338
Jun 22, 2023 $1.53 $1.55 $1.51 $1.52 157 663
Jun 21, 2023 $1.51 $1.55 $1.46 $1.54 403 534
Jun 20, 2023 $1.54 $1.55 $1.51 $1.53 293 709
Jun 16, 2023 $1.57 $1.57 $1.52 $1.55 300 217
Jun 15, 2023 $1.58 $1.58 $1.52 $1.56 267 023
Jun 14, 2023 $1.65 $1.67 $1.57 $1.57 316 553
Jun 13, 2023 $1.67 $1.69 $1.64 $1.67 340 465
Jun 12, 2023 $1.68 $1.71 $1.67 $1.68 174 982
Jun 09, 2023 $1.75 $1.77 $1.67 $1.68 204 939
Jun 08, 2023 $1.70 $1.75 $1.69 $1.74 283 767
Jun 07, 2023 $1.70 $1.72 $1.67 $1.72 166 974
Jun 06, 2023 $1.72 $1.72 $1.68 $1.69 126 316
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT